Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
bioAffinity Technologies, Inc. (BIAF) had Return on Equity of -204.87% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.16M |
|
$-14.91M |
|
$4.23M |
|
$1.94M |
|
$16.73M |
|
$-10.57M |
|
$-4.29M |
|
$-14.87M |
|
$-14.87M |
|
$-14.91M |
|
$-14.91M |
|
$-14.91M |
|
$-14.91M |
|
$-10.57M |
|
$-10.07M |
|
1.72M |
|
1.72M |
|
$-8.66 |
|
$-8.66 |
|
| Balance Sheet Financials | |
$7.57M |
|
$0.27M |
|
$3.40M |
|
$10.96M |
|
$2.91M |
|
$0.57M |
|
$0.78M |
|
$3.68M |
|
$7.28M |
|
$5.16M |
|
$7.28M |
|
4.50M |
|
| Cash Flow Statement Financials | |
$-9.33M |
|
$-0.06M |
|
$14.73M |
|
$1.11M |
|
$6.45M |
|
$5.34M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.60 |
|
-- |
|
-- |
|
0.07 |
|
0.11 |
|
31.41% |
|
-171.58% |
|
-171.58% |
|
-163.38% |
|
-241.25% |
|
-241.96% |
|
$-9.39M |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
78.93 |
|
11.37 |
|
32.10 |
|
|
Return on Equity |
-204.87% |
-289.15% |
|
-136.03% |
|
-189.89% |
|
$1.62 |
|
$-5.46 |
|
$-5.42 |
|